ESB-13895-96199
4 vaccinations
3 coded responses
27 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 993 / WA
- Registered
- 2021-03-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-13
Dose 1 — Pfizer-BioNTech
-
2021-03-15
Registered in v-safe
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-27
-
2021-04-03
Dose 2 — Pfizer-BioNTech
- 2021-04-03
-
2021-04-04
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: Pain at shot location was mild after the shot on 4/3/21 and by evening pain was moderate (muscle stiffness). But pn Sunday morning pain had decreased to mild and seems less and less as time passes.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: Good · Site: Pain · Muscle or body achesFree text: Mild pain at shot location has decreased more from yesterday. Noticeable pain if pressure is applied to the shot location. "Mild pain" is probably too strong a description.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-11
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-05-15
-
2021-07-04
Survey response — 3 months, dose 2MedDRA: Body temperature increased, Diarrhoea, Gastroenteritis viral, Vomiting, Weight decreased — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Stomach virus of some kind. Vomiting and diarrhea. 101 degree temperature for one day. Lost 6 lbs., in 4 days. Fully recovered and no lingering issues.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-02
-
2022-01-28
Dose 3 — ModernaCo-administered: Shingles
- 2022-04-03
-
2022-04-05
Dose 4 — Moderna
- 2022-04-29
- 2022-07-05
- 2022-10-04
- 2023-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Pfizer-BioNTech | |
| 2 | 2021-04-03 | Pfizer-BioNTech | |
| 3 | 2022-01-28 | Moderna | Shingles |
| 4 | 2022-04-05 | Moderna | No |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Pain at shot location was mild after the shot on 4/3/21 and by evening pain was moderate (muscle stiffness). But pn Sunday morning pain had decreased to mild and seems less and less as time passes.
Systemic reaction (other): Mild pain at shot location has decreased more from yesterday. Noticeable pain if pressure is applied to the shot location. "Mild pain" is probably too strong a description.
Release 9 — 3 months, dose 2
Symptoms: Stomach virus of some kind. Vomiting and diarrhea. 101 degree temperature for one day. Lost 6 lbs., in 4 days. Fully recovered and no lingering issues.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Gastroenteritis viral | ✓ | ✓ | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SD | Weight decreased | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release